Status:
UNKNOWN
Process Evaluation of OptimiseRx and PINCER
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Conditions:
Medication Errors
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to evaluate two interventions designed to make medication prescribing safer, OptimiseRx and PINCER, which are being used in general practices across England. The findings from the eval...
Detailed Description
This study has been designed to evaluate and gain an understanding of the 'real world' implementation, fidelity and medium and longer-term embedding and sustainability of two prescribing safety interv...
Eligibility Criteria
Inclusion
- Staff and stakeholders
- Able to give written informed consent
- 18 years of age or over (no maximum age limit)
- Staff members working in/for a practice or a CCG or the software developer which has received the intervention/s and have direct contact with it/them
- Staff from relevant AHSNs, NHS England, the University of Nottingham or PRIMIS and other relevant staff who have had involvement in the PINCER rollout
- Staff who have either had direct contact with, have an understanding of and/or are in a position to influence wider adoption of the PINCER and OptimseRx interventions (e.g. contracting, IT systems engineer, commissioner, etc.)
- Patients
- Able to give written informed consent
- 18 years of age or over (no maximum age limit)
- Patients registered with a general practice who have attended a consultation (or other related activity) for the PINCER intervention, or selected by their clinical care team, or attached to a patient group within a CCG or practice or those identified via social media who are living with a long-term health condition and/or who require regular blood tests to monitor their medication and have had a medication review within the past six months
- Members of the public and patient representatives
- Able to give written informed consent
- 18 years of age or over (no maximum age limit)
- Those who have either had direct contact with the PINCER intervention or have an understanding of the related medicines management issues in primary care
Exclusion
- Staff and stakeholders
- Unable to give written informed consent
- Under 18 years of age
- Patients
- Unable to give written informed consent
- Under 18 years of age
- Those considered by their healthcare professional to be inappropriate to recruit due to psycho-social reasons or significant health reasons, e.g. terminal illness/diagnosis.
- Members of the public and patient representatives
- Unable to give written informed consent
- Under 18 years of age
Key Trial Info
Start Date :
February 16 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2023
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT04766619
Start Date
February 16 2018
End Date
February 28 2023
Last Update
February 23 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Edinburgh
Edinburgh, United Kingdom
2
University of Manchester
Manchester, United Kingdom, M13 9PT
3
University of Nottingham
Nottingham, United Kingdom, NG7 2RD